Dossier · BJRI · Dormant
BJRI · BJ's Restaurants, Inc. · Stock research
Last analysed ·
Current thesis
Casual-dining turnaround already re-rated: seven straight quarters of traffic growth under CEO Tick, but Q1 comps decelerated to +2.4%, FY guide is just +1–3%, price sits ~30% above every analyst PT, and insiders sold the June high. Mature narrative, not accelerating, into a ~2026-07-30 Q2 binary.
Invalidation trigger
A weekly close below $50 (loses the spring breakout base and the uptrend from the $28.46 low), or a ~2026-07-30 Q2 print with comps turning flat-to-negative and a cut FY margin guide.
Thesis status
Open commitment catalyst in 15dscored if the trigger above fires How this is scored →Latest analysis and events for BJRI —
As of 2026-07-12, orbyd's latest analysis for BJ's Restaurants, Inc. (BJRI): Casual-dining turnaround already re-rated: seven straight quarters of traffic growth under CEO Tick, but Q1 comps decelerated to +2.4%, FY guide is just +1–3%, price sits ~30% above every analyst PT, and insiders sold the June high. Mature narrative, not accelerating, into a ~2026-07-30 Q2 binary.
Invalidation trigger: A weekly close below $50 (loses the spring breakout base and the uptrend from the $28.46 low), or a ~2026-07-30 Q2 print with comps turning flat-to-negative and a cut FY margin guide.
Next dated event on file: — catalyst in 15d.
Current Thesis
BJ's is a casual-dining operational turnaround that the market has already paid for. Under CEO Lyle Tick the chain has strung together seven straight quarters of sales and traffic growth plus multi-quarter restaurant-level margin expansion, and the stock roughly doubled off its $28.46 52-week low to ~$59. But the narrative has matured rather than accelerated: Q1 2026 comps decelerated to +2.4%, FY guide is only +1% to +3%, the price sits ~30% above every published analyst target, and insiders sold into the June high. This is a stretched, late-cycle self-help name heading into a July 30 earnings binary, not a fresh accelerating setup.
Bullish and bearish views on BJ's Restaurants, Inc.
The model's bull view on BJ's Restaurants, Inc. (BJRI), in brief: Q1 2026 (quarter ended 2026-03-31): comps +2.4% on +2.2% traffic the seventh consecutive quarter of sales and traffic growth in a casual-dining tape where peer traffic is largely flat-to-negative. The bear view: Price ~$59 (2026-07-06) vs a median analyst target of ~$42–44 (range $38–50) the stock trades above every target on the Street, roughly 30% of implied downside to consensus fair value. Both cases follow in full.
Bull Case
- Q1 2026 (quarter ended 2026-03-31): comps +2.4% on +2.2% traffic the seventh consecutive quarter of sales and traffic growth in a casual-dining tape where peer traffic is largely flat-to-negative.
- Revenue $358.1M, +2.9% YoY, a slight beat vs $356.97M consensus.
- Restaurant-level operating profit $57.2M at a 16.0% margin (+2.8% YoY); adjusted EBITDA $37.7M at a 10.5% margin, +30bps YoY the sixth straight quarter of EBITDA-margin expansion.
- FY2025 restaurant-level operating profit reached $216.2M at a 15.5% margin, evidence the margin recovery is structural and multi-year, not a one-quarter blip.
- Pizookie Meal Deal everyday-value platform is the traffic driver; management credits it for sustained guest counts through 2025 into Q1 2026.
- FY2026 targets set at the Q4 2025 print (~Feb 2026): restaurant-level operating profit $221–233M, adjusted EBITDA $140–150M, and up to $50M of buybacks a shareholder-return lever on top of the operating story.
- Trailing 12-month return ~+18%, beating the US Hospitality group (+16.7%) over the same span.
Bear Case
- Price ~$59 (2026-07-06) vs a median analyst target of ~$42–44 (range $38–50) the stock trades above every target on the Street, roughly 30% of implied downside to consensus fair value.
- Insider cluster-selling into the June high: CIO Brian Krakower sold 7,341 sh @ $55.17 on 2026-06-18 (cutting his stake ~61%); Director Lea Anne Ottinger 2,792 @ $53.50 (2026-06-18); Chief Development Officer Gregory Lynds sold on 2026-06-11 and 2026-06-18;
- Q1 2026 adjusted EPS $0.57 missed the $0.61 consensus; GAAP diluted EPS was $0.41 and net margin sits near 3.15% thin cushion against labor or commodity re-inflation.
- Growth lags the peer group: projected ~12.9% earnings and ~4.1% revenue growth against restaurant-industry averages near 21.4% and 5.4%, yet the stock carries a ~21.7x forward P/E for 1–3% comps.
- FY2026 comp guide of +1% to +3% is a deceleration from the recovery run-rate; the easy comparisons are behind it.
Setup & Price Structure
- ~$59.15 (2026-07-06), pinned just under the 52-week high of $60.77; 52-week low $28.46.
- The move is extended and near-vertical into the high June 28 prior close $56.33 ran to ~$59.86 leaving price stretched well above near-term support.
- Trading above all analyst targets. In a genuinely accelerating name that is confirmation; here, with decelerating comps and a multiple that has already re-rated, it reads as late-cycle stretch rather than fresh breakout thrust.
- The structural base of the advance sits around the $50 round number / spring breakout shelf; the rising trend line off the $28.46 low is the level that defines whether the turnaround re-rating is intact.
Catalyst Calendar (next 30 days)
- ~2026-07-30 (est.): Fiscal Q2 2026 earnings. Q2 is BJ's seasonal peak quarter; consensus sits near $0.84 EPS. The swing factors are comp/traffic trajectory and any FY margin-guide revision a binary event that argues for standing aside on fresh entries into the print.
- No FDA, analyst-day, or other dated catalyst in the 30-day window.
What Would Change Our Mind
- Re-acceleration: a Q2 print (~2026-07-30) with comps back above +3%, traffic re-accelerating, and a raised FY guide would revive the ACCELERATING case and justify chasing strength.
- Thesis break: a weekly close below $50 — that loses the spring breakout base and the uptrend from the $28.46 low, or a Q2 print showing comps turning flat-to-negative with a cut margin guide.
- Street catching up: analyst targets migrating up toward the tape would flip the "above every target" flag from a mean-reversion risk into momentum confirmation.
Correlation Notes
- Moves with the casual-dining / consumer-discretionary-rotation complex EAT (Brinker/Chili's), TXRH, DRI, CAKE, PLAY. The margin-self-help-plus-value-platform playbook rhymes closely with Brinker's Chili's turnaround.
- Sensitive to consumer-spending macro (jobs, real income) and to labor and commodity inflation on the cost line, given the thin net margin.
- Low correlation to the AI/tech leadership driving the broad index; beta to SPY is modest. This is an idiosyncratic self-help story that lives and dies on its own comps and margin print, not the index tape.
Notes
- Q2 2026 earnings ~2026-07-30 (est., unconfirmed exact date — sources split July 23 vs July 30); treat as blackout for fresh entries within 3 trading days.
- Above-Street flag: ~$59 price vs median PT ~$42-44 (range $38-50) as of late-June/early-July 2026 every analyst target is below spot.
- Insider cluster-sell into the June high: ~63,817 sh / $3.38M over 90 days (CIO Krakower -61% of stake, plus Ottinger/Lynds/Rogers).
- Narrative is MATURING-to-SATURATED at this price, not accelerating comps decelerating to +1-3% guide; not a momentum-book fresh-entry setup at ~$59.
- Turnaround CEO Lyle Tick; Pizookie Meal Deal is the value/traffic driver.
Related · shared themes
MTUM
May 2026 reconstitution rotated MTUM hard into the AI-memory/semiconductor complex (MU 7.2%, INTC, AMD, AVGO, LRCX, AMAT ~30%+ combined); the factor now trades as a leveraged AI-hardware proxy, +30% YTD and pressed against its $345.59 52-week high. Underlying accelerating, but crowded and late in the reconstitution cycle.
WEST
Westrock Coffee Company
Conway extract/RTD platform inflecting capex to cash: Q1 (5/07) beat revenue with record adjusted EBITDA, FCF-positive-H2 guide reaffirmed, and a 6/30 debt-maturity extension cleared the near-term refi wall. Stock re-rated ~the published invalidation level→$9.50 near the $9.81 high on PT hikes real and accelerating, but a fresh entry above the ~$8.88 average PT into an ~8-week gap to Q2 (~8/6) is extended.
ALGT
Allegiant Travel Company
A three-week sell-side upgrade cascade (Goldman $125→$142, JPM initiates OW $156, Citi/Melius Buy $156–$160, Barclays OW $145) plus a fuel-cost tailwind as the Hormuz crude spike unwinds has re-rated Allegiant's post-Sunseeker ULCC turnaround. Theme is accelerating with the whole airline complex (JETS at pre-Covid highs), but the move has more than doubled off the low into a seasonally soft Q2 print on ~2026-08-03.
AFRM
Affirm Holdings, Inc.
Q3 FY26 killed the credit-stress bear case (GMV +35%, first GAAP operating profit, clean delinquency), and a July sell-side cluster six PT raises/initiations to $96–$117 in ten days is accelerating the re-rate off the mid-June 200-day reclaim (~$74). Momentum confirms, but the move is stretched into a maturing analyst pile-in near the prior $100 high, with no company catalyst until the ~mid-August print.
See also · stocks to watch